David G. Menter
Affiliations: | The University of Texas Graduate School of Biomedical Sciences at Houston |
Area:
Cell Biology, Oncology, Molecular BiologyGoogle:
"David Menter"Children
Sign in to add trainee
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| McGrail DJ, Garnett J, Yin J, et al. (2020) Proteome Instability Is a Therapeutic Vulnerability in Mismatch Repair-Deficient Cancer. Cancer Cell |
| Sahni N, McGrail DJ, Garnett J, et al. (2020) Abstract NG14: Proteome instability is an immunogenic therapeutic vulnerability in mismatch repair deficient cancer Cancer Research. 80 |
| Korphaisarn K, Morris V, Davis JS, et al. (2019) Signet ring cell colorectal cancer: genomic insights into a rare subpopulation of colorectal adenocarcinoma. British Journal of Cancer |
| Ravoori MK, Margalit O, Singh S, et al. (2019) Magnetic Resonance Imaging and Bioluminescence Imaging for Evaluating Tumor Burden in Orthotopic Colon Cancer. Scientific Reports. 9: 6100 |
| Willauer AN, Liu Y, Pereira AAL, et al. (2019) Clinical and molecular characterization of early-onset colorectal cancer. Cancer |
| Menter DG, Davis JS, Broom BM, et al. (2019) Back to the Colorectal Cancer Consensus Molecular Subtype Future. Current Gastroenterology Reports. 21: 5 |
| Varkaris A, Katsiampoura A, Davis JS, et al. (2019) Circulating inflammation signature predicts overall survival and relapse-free survival in metastatic colorectal cancer. British Journal of Cancer |
| Frias RL, Lam M, Overman MJ, et al. (2019) Meat consumption and BRAF mutation status in colorectal cancer. Journal of Clinical Oncology. 37 |
| Chung SW, Overman MJ, Morris VK, et al. (2019) The association between female hormonal supplementation and molecular types in colorectal cancer. Journal of Clinical Oncology. 37 |
| Nusrat M, Roszik J, Katkhuda R, et al. (2019) Association of PIK3CA mutations (mut) with immune engagement and clinical benefit from immunotherapy in microsatellite stable (MSS) colorectal cancer (CRC) patients (pts). Journal of Clinical Oncology. 37: 3604-3604 |